GDF11 Alleviates Vascular Calcification in VitD 3 ‐Overloaded Mice Through Inhibition of Inflammatory NF‐κB Signal
- 28 May 2025
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 39 (11) , e70677
Abstract
Vascular calcification, an age‐associated disorder, is a highly regulated biological process similar to bone formation. Growth differentiation factor 11 (GDF11), a secreted member of the transforming growth factor beta (TGF‐β) superfamily, has been shown to act as an anti‐aging factor in the brain, heart, skin, and skeletal muscle. Nevertheless, whether GDF11 affects vascular calcification and the underlying mechanisms remain unclear. In the present study, beta‐glycerophosphate and calcium chloride‐induced calcification of vascular smooth muscle cells (VSMCs) and a VitD 3 ‐overloaded mouse model were used to investigate the role of GDF11 in vascular calcification. Our results revealed that the knockdown of GDF11 by siRNA promoted the calcification of rat VSMCs, whereas GDF11 treatment significantly reduced the calcification of human and rat VSMCs in vitro, as detected by alizarin red staining and calcium content assay. Similarly, GDF11 treatment reduced the expression of bone‐related molecules including Runt‐related transcription factor 2 (Runx2) and bone morphogenetic protein‐2 (BMP2). Furthermore, ex vivo and in vivo studies confirmed the inhibitory effect of GDF11 on vascular calcification. Mechanistically, GDF11 treatment reduced the levels of NF‐κB signaling molecules including NLRP3, phosphorylated p65, IL‐6, and IL‐1β in VSMCs. Additionally, GDF11 siRNA‐induced VSMC calcification was repressed by NF‐κB inhibitor PDTC treatment. Taken together, these findings suggest that GDF11 alleviates vascular calcification through inhibiting the NF‐κB signal. Modulation of GDF11 may represent a therapeutic strategy for vascular calcification.Keywords
Funding Information
- National Natural Science Foundation of China (82170414, 82370418)
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515012864)
This publication has 60 references indexed in Scilit:
- Global Trends in Atherosclerotic Cardiovascular DiseaseClinical Therapeutics, 2023
- Bone Mineral Density and Vascular Calcification in Children and Young Adults With CKD 4 to 5 or on DialysisKidney International Reports, 2022
- Downregulation of HDAC9 by the ketone metabolite β‐hydroxybutyrate suppresses vascular calcificationThe Journal of Pathology, 2022
- Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney diseaseFree Radical Biology and Medicine, 2021
- Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia–reperfusion injuryBasic Research in Cardiology, 2019
- Inflammation induces endothelial‐to‐mesenchymal transition and promotes vascular calcification through downregulation of BMPR2The Journal of Pathology, 2018
- GDF11 Antagonizes Psoriasis-like Skin Inflammation via Suppression of NF-κB Signaling PathwayInflammation, 2018
- Elevated GDF11 Is a Risk Factor for Age-Related Frailty and Disease in HumansCell Metabolism, 2016
- GDF11 Increases with Age and Inhibits Skeletal Muscle RegenerationCell Metabolism, 2015
- Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac HypertrophyCell, 2013